Dr Paul Dunn, Chair, IHMA
Pharmaceutical manufacturers are being urged to review their anti-counterfeiting plans ahead of the possible failure by the UK government to agree a Brexit deal with the EU.
Global trade body International Hologram Manufacturers Association (IHMA) said the UK could see a flood of counterfeit medicines after the Falsified Medicines Directive (FMD) ceases to apply at the end of the Brexit transition period on 1st January 2021.
- THE EDITORIAL TEAM
- Industry News
- Posted On